• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Document › Details

Biognosys AG. (1/3/12). "Press Release: Biognosys and ETH Zurich Receive CHF 1.5m Funding from CTI".

	Region	Switzerland
	Organisation	Biognosys AG
	Organisation 2	KTI Innovation Promotion Agency (CTI / KTI) (CH)
	Group	Switzerland (govt)
	Product	HRM-MS technology (Hyper Reaction Monitoring)
	Product 2	proteomic technology
	Index term	Biognosys–Switzerland (govt): grant, 201201 grant CHF1.5m to Biognosys + Aebersold Group at ETH Zurich for developm of HRM-MS technology
	Index term 2	Biognosys–ETH Zürich: HRM-MS technology, 201201 collab development Aebersold group
	Person	Aebersold, Ruedi (ETH Zurich 2005c– Professor Systems Biology before Institute of Systems Biology Seattle)

The Swiss Commission for Technology and Innovation (CTI) has granted CHF 1.5m for a research collaboration between Biognosys and the group of Prof. Aebersold, ETH Zurich, to bring the novel HRM-MS technology to the market.

Hyper Reaction Monitoring (HRM) is the next generation proteomics technology based on data independent acquisition (e.g. SWATH) that enables simultaneous measurement of 1000s of known and unknown proteins in a sample and subsequent extraction of protein profile data. Moreover, proteins in a sample measured with HRM can be easily analyzed retrospectively, including proteins that were not known or not considered relevant at the time of sample measurement. This innovative concept of "digital bio-banking" can potentially revolutionize clinical research and diagnostic. Biognosys has already achieved substantial advances in the development of HRM and now with the CTI support and in collaboration with EHT Zurich plans to bring the technology to the market.

With HRM Biognosys aims to provide consumers with a personal protein passport that contains snapshots of blood proteins tracked over a life-time. Such a digital protein passport, serving as a lifelong history of one`s own protein profile, is a powerful tool to monitor health / detect onset of diseases, and to preserve information for future advances in diagnostics and treatment.

Record changed: 2012-01-24

More documents for Biognosys AG

• [1] [iito] Business Intelligence. (3/13/12). "[MSC] Newsletter February 2012". Bremen....
• [2] Biognosys AG. (2/16/12). "Press Release: Skyline, the Most Popular Software for Targeted Proteomics Integrates Now iRT"....
• [3] Biognosys AG. (12/7/11). "Press Release: Biognosys Collaborates with M2 to Develop Commercial MRM Software"....
• [4] Biognosys AG. (10/31/11). "Press Release: Biognosys Raises CHF 2.7m in Series A Financing. Biognosys Attracted Venture Capital from Experienced Investors including Syngenta Ventures"....
• [5] Biognosys AG. (9/16/11). "Press Release: iRT Concept Is Gaining Acceptance. Biognosys Is Invited to Present Its iRT Concept for Mass Spectrometry Specialists"....
• [6] Biognosys AG. (9/9/11). "Press Release: Biognosys Celebrates 3rd Anniversary. On September 9th, 2011, Biognosys Turns 3 Years Old..."....
• [7] Biognosys AG. (8/4/11). "Press Release: Meet Biognosys at HUPO / Geneva. Biognosys AG Is Participating in the 10th Annual World Congress of the Human Proteome Organisation in Geneva"....
• [8] Biognosys AG. (7/4/11). "Press Release: Deal with Novartis Vaccines and Diagnostics. Siena, Italy – Biognosys Is Entering into a Collaboration with Novartis Vaccines and Diagnostics"....
• [9] Biognosys AG. (5/24/11). "Press Release: MRMbase.com. The World’s Most Validated Library of Mass Spec Assays"....
• [10] Biognosys AG. (5/24/11). "Press Release: Biognosys at ASMS / Denver"....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.